You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

FOAMCOAT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Foamcoat patents expire, and when can generic versions of Foamcoat launch?

Foamcoat is a drug marketed by Guardian Drug and is included in one NDA.

The generic ingredient in FOAMCOAT is aluminum hydroxide; magnesium trisilicate. There are one hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOAMCOAT?
  • What are the global sales for FOAMCOAT?
  • What is Average Wholesale Price for FOAMCOAT?
Summary for FOAMCOAT
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 7
Patent Applications: 75
DailyMed Link:FOAMCOAT at DailyMed
Drug patent expirations by year for FOAMCOAT

US Patents and Regulatory Information for FOAMCOAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Guardian Drug FOAMCOAT aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 071793-001 Sep 4, 1987 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

FOAMCOAT Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for FOAMCOAT Antacid

Introduction to FOAMCOAT Antacid

FOAMCOAT Antacid, manufactured by Guardian Drug Company, is an over-the-counter (OTC) medication designed to provide relief from heartburn, indigestion, and upset stomach. It contains active ingredients such as aluminum hydroxide and magnesium carbonate, which work to neutralize stomach acid and provide quick relief.

Market Context: Antacids and Acid Reducers

The market for antacids and acid reducers is part of the broader gastrointestinal (GI) health products sector. This market is driven by increasing prevalence of GI disorders, lifestyle factors, and an aging population.

Global Antacid Market Overview

The global antacid market is expected to grow due to rising demand for over-the-counter medications that address gastrointestinal issues. Here are some key points:

  • Growing Demand: The increasing incidence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), peptic ulcers, and other digestive issues, drives the demand for antacids[4].
  • Lifestyle Factors: Changes in diet, stress levels, and other lifestyle factors contribute to the growing need for antacid medications.
  • Aging Population: An aging population is more prone to GI issues, further boosting the demand for antacids.

Competitive Landscape

The antacid market is highly competitive, with several established brands and generic options available.

  • Key Players: Major pharmaceutical companies and generic drug manufacturers compete in this space. Companies like Johnson & Johnson, Pfizer, and generic manufacturers such as Guardian Drug Company, play significant roles[4].
  • Product Differentiation: FOAMCOAT Antacid differentiates itself through its unique formulation and brand recognition, which can influence consumer preference.

Financial Trajectory for FOAMCOAT Antacid

To understand the financial trajectory of FOAMCOAT Antacid, we need to look at several factors:

Revenue and Market Share

  • The revenue generated by FOAMCOAT Antacid would be part of the broader antacid market. Given the competitive nature of the market, maintaining or increasing market share is crucial.
  • Market Size: The global antacid market is substantial, and while specific figures for FOAMCOAT Antacid are not available, it is part of a market that is expected to grow steadily.

Cost Structure

  • Production Costs: The cost of producing FOAMCOAT Antacid includes raw materials, manufacturing, and distribution expenses. Efficient production and supply chain management are essential to maintain profitability.
  • Marketing and Advertising: Significant investments in marketing and advertising are necessary to maintain brand visibility and attract consumers in a crowded market.

Pricing Strategy

  • Competitive Pricing: FOAMCOAT Antacid must be competitively priced to attract consumers. Pricing strategies may include discounts, promotions, and loyalty programs to retain customers.
  • Value Proposition: The unique formulation and brand reputation of FOAMCOAT Antacid can justify premium pricing, but this must be balanced against consumer sensitivity to price.

Market Drivers and Challenges

Market Drivers

  • Increasing Prevalence of GI Disorders: The rising incidence of gastrointestinal disorders drives the demand for antacids like FOAMCOAT.
  • Consumer Awareness: Growing consumer awareness about health and wellness contributes to the demand for over-the-counter medications.
  • Convenience: The availability of FOAMCOAT Antacid as an OTC medication makes it a convenient option for consumers.

Market Challenges

  • Competition: The antacid market is highly competitive, with many established brands and generic options available.
  • Regulatory Compliance: FOAMCOAT Antacid must comply with regulatory requirements, which can be a challenge, especially in a global market.
  • Economic Factors: Economic downturns can affect consumer spending on non-essential items, including OTC medications.

Regional Market Dynamics

North America

  • The North American market is significant for antacids, driven by a large consumer base and high awareness of GI health issues.
  • Consumer Preferences: Consumers in North America often prefer well-known brands, which can benefit FOAMCOAT Antacid if it has strong brand recognition.

Asia Pacific

  • The Asia Pacific region is also a key market, with growing demand driven by increasing awareness of GI health and an expanding middle class.
  • Local Competition: Local brands and generic options are prevalent in this region, posing a challenge to FOAMCOAT Antacid.

Innovations and Trends

Innovative Formulations

  • The development of new formulations, such as fast-acting or long-lasting antacids, can provide a competitive edge.
  • Natural Ingredients: There is a growing trend towards natural and organic products, which could influence the formulation and marketing of FOAMCOAT Antacid.

Digital Marketing

  • Digital marketing strategies, including online advertising and social media campaigns, are crucial for reaching a wider audience and maintaining brand visibility.

Key Takeaways

  • Growing Demand: The antacid market is driven by increasing prevalence of GI disorders and lifestyle factors.
  • Competitive Landscape: FOAMCOAT Antacid operates in a highly competitive market, requiring strong brand recognition and competitive pricing.
  • Regional Dynamics: Different regions present unique opportunities and challenges, with North America and Asia Pacific being key markets.
  • Innovations: Staying ahead with innovative formulations and marketing strategies is essential for maintaining market share.

FAQs

  1. What are the main ingredients in FOAMCOAT Antacid?

    • FOAMCOAT Antacid contains aluminum hydroxide and magnesium carbonate as its active ingredients[5].
  2. How does FOAMCOAT Antacid differentiate itself in the market?

    • FOAMCOAT Antacid differentiates itself through its unique formulation and brand recognition.
  3. What are the key drivers of the antacid market?

    • The key drivers include the increasing prevalence of GI disorders, consumer awareness, and convenience of OTC medications.
  4. Which regions are most significant for the antacid market?

    • North America and the Asia Pacific region are significant markets due to their large consumer bases and growing awareness of GI health.
  5. How can FOAMCOAT Antacid stay competitive in the market?

    • By focusing on innovative formulations, competitive pricing, strong brand recognition, and effective digital marketing strategies.

Cited Sources

  1. Healthcare Packaging - Medical Foam Market is Expected to Grow to $47.2 Billion by 2030
  2. Sutro Biopharma - Sutro Biopharma Reports Second Quarter 2024 Financial Results ...
  3. Polaris Market Research - Global Foam Market Size, Share & Growth Analysis Report, 2023 ...
  4. Grand View Research - Anti-Foaming Agents Market Size And Share Report, 2030
  5. FDA Report - FOAMCOAT ANTACID- aluminum hydroxide, magnesium carbonate ...

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.